APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tissue Heart Valves Device

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tissue Heart Valves Device Industry Growth and Trends Forecast to 2032

4 July 2026100 pages

Choose your research edition.

Industry ResearchTissue Heart Valves Device Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Tissue Heart Valves Device Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Tissue Heart Valves Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tissue Heart Valves Device Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Tissue Heart Valves Device Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Tissue Heart Valves Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tissue Heart Valves Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tissue Heart Valves Device is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tissue Heart Valves Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tissue Heart Valves Device include Boston Scientific Corporation, Comed BV, CryoLife, Edward Lifesciences Corporation, JenaValve Technology Inc, Meril Life Sciences, On-X Life Technologies, Inc, Sorin Group and TTK Healthcare Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tissue Heart Valves Device market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tissue Heart Valves Device market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tissue Heart Valves Device market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tissue Heart Valves Device.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tissue Heart Valves Device market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tissue Heart Valves Device Market by Company

Boston Scientific Corporation

Comed BV

CryoLife

Edward Lifesciences Corporation

JenaValve Technology Inc

Meril Life Sciences

On-X Life Technologies, Inc

Sorin Group

TTK Healthcare Limited

Beijing Balance Medical Technology Co., Ltd

Medtronic

Abbott

Tissue Heart Valves Device Segment by Type

Aortic Valve

Tricuspid Valve

Pulmonary Valve

Mitral Valve

Tissue Heart Valves Device Segment by Application

Ambulatory Surgical Centers

Hospitals

Clinics

Tissue Heart Valves Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tissue Heart Valves Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tissue Heart Valves Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tissue Heart Valves Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tissue Heart Valves Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tissue Heart Valves Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Aortic Valve Table 2. Major Company of Tricuspid Valve Table 3. Major Company of Pulmonary Valve Table 4. Major Company of Mitral Valve Table 5. Global Tissue Heart Valves Device Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Tissue Heart Valves Device Sales by Type (2021-2026) & (k units) Table 7. Global Tissue Heart Valves Device Sales Market Share in Volume by Type (2021-2026) Table 8. Global Tissue Heart Valves Device Sales by Type (2021-2026) & (US$ Million) Table 9. Global Tissue Heart Valves Device Sales Market Share in Value by Type (2021-2026) Table 10. Global Tissue Heart Valves Device Price by Type (2021-2026) & (USD/unit) Table 11. Global Tissue Heart Valves Device Sales by Type (2027-2032) & (k units) Table 12. Global Tissue Heart Valves Device Sales Market Share in Volume by Type (2027-2032) Table 13. Global Tissue Heart Valves Device Sales by Type (2027-2032) & (US$ Million) Table 14. Global Tissue Heart Valves Device Sales Market Share in Value by Type (2027-2032) Table 15. Global Tissue Heart Valves Device Price by Type (2027-2032) & (USD/unit) Table 16. North America Tissue Heart Valves Device Sales by Type (2021-2026) & (k units) Table 17. North America Tissue Heart Valves Device Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Tissue Heart Valves Device Sales by Type (2021-2026) & (k units) Table 19. Europe Tissue Heart Valves Device Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Tissue Heart Valves Device Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Tissue Heart Valves Device Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Tissue Heart Valves Device Sales by Type (2021-2026) & (k units) Table 23. Latin America Tissue Heart Valves Device Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Tissue Heart Valves Device Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Tissue Heart Valves Device Sales by Type (2021-2026) & (US$ Million) Table 26. Tissue Heart Valves Device Industry Trends Table 27. Tissue Heart Valves Device Industry Drivers Table 28. Tissue Heart Valves Device Industry Opportunities and Challenges Table 29. Tissue Heart Valves Device Industry Restraints Table 30. Global Tissue Heart Valves Device Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Tissue Heart Valves Device Revenue Market Share by Company (2021-2026) Table 32. Global Tissue Heart Valves Device Sales by Company (2021-2026) & (k units) Table 33. Global Tissue Heart Valves Device Sales Share by Company (2021-2026) Table 34. Global Tissue Heart Valves Device Market Price by Company (2021-2026) & (USD/unit) Table 35. Global Tissue Heart Valves Device Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Tissue Heart Valves Device Major Company Production Sites and Headquarters Table 37. Global Tissue Heart Valves Device Company, Product Type & Application Table 38. Global Tissue Heart Valves Device Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Tissue Heart Valves Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Tissue Heart Valves Device Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Tissue Heart Valves Device Sales by Region (2021-2026) & (k units) Table 43. Global Tissue Heart Valves Device Sales Market Share in Volume by Region (2021-2026) Table 44. Global Tissue Heart Valves Device Sales by Region (2021-2026) & (US$ Million) Table 45. Global Tissue Heart Valves Device Sales Market Share in Value by Region (2021-2026) Table 46. Global Tissue Heart Valves Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 47. Global Tissue Heart Valves Device Sales by Region (2027-2032) & (k units) Table 48. Global Tissue Heart Valves Device Sales Market Share in Volume by Region (2027-2032) Table 49. Global Tissue Heart Valves Device Sales by Region (2027-2032) & (US$ Million) Table 50. Global Tissue Heart Valves Device Sales Market Share in Value by Region (2027-2032) Table 51. Global Tissue Heart Valves Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 52. Global Tissue Heart Valves Device Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Tissue Heart Valves Device Sales by Application (2021-2026) & (k units) Table 54. Global Tissue Heart Valves Device Sales Market Share in Volume by Application (2021-2026) Table 55. Global Tissue Heart Valves Device Sales by Application (2021-2026) & (US$ Million) Table 56. Global Tissue Heart Valves Device Sales Market Share in Value by Application (2021-2026) Table 57. Global Tissue Heart Valves Device Price by Application (2021-2026) & (USD/unit) Table 58. Global Tissue Heart Valves Device Sales by Application (2027-2032) & (k units) Table 59. Global Tissue Heart Valves Device Sales Market Share in Volume by Application (2027-2032) Table 60. Global Tissue Heart Valves Device Sales by Application (2027-2032) & (US$ Million) Table 61. Global Tissue Heart Valves Device Sales Market Share in Value by Application (2027-2032) Table 62. Global Tissue Heart Valves Device Price by Application (2027-2032) & (USD/unit) Table 63. North America Tissue Heart Valves Device Sales by Application (2021-2026) & (k units) Table 64. North America Tissue Heart Valves Device Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Tissue Heart Valves Device Sales by Application (2021-2026) & (k units) Table 66. Europe Tissue Heart Valves Device Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Tissue Heart Valves Device Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Tissue Heart Valves Device Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Tissue Heart Valves Device Sales by Application (2021-2026) & (k units) Table 70. Latin America Tissue Heart Valves Device Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Tissue Heart Valves Device Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Tissue Heart Valves Device Sales by Application (2021-2026) & (US$ Million) Table 73. Boston Scientific Corporation Company Information Table 74. Boston Scientific Corporation Business Overview Table 75. Boston Scientific Corporation Tissue Heart Valves Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Boston Scientific Corporation Tissue Heart Valves Device Product Portfolio Table 77. Boston Scientific Corporation Recent Development Table 78. Comed BV Company Information Table 79. Comed BV Business Overview Table 80. Comed BV Tissue Heart Valves Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Comed BV Tissue Heart Valves Device Product Portfolio Table 82. Comed BV Recent Development Table 83. CryoLife Company Information Table 84. CryoLife Business Overview Table 85. CryoLife Tissue Heart Valves Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. CryoLife Tissue Heart Valves Device Product Portfolio Table 87. CryoLife Recent Development Table 88. Edward Lifesciences Corporation Company Information Table 89. Edward Lifesciences Corporation Business Overview Table 90. Edward Lifesciences Corporation Tissue Heart Valves Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Edward Lifesciences Corporation Tissue Heart Valves Device Product Portfolio Table 92. Edward Lifesciences Corporation Recent Development Table 93. JenaValve Technology Inc Company Information Table 94. JenaValve Technology Inc Business Overview Table 95. JenaValve Technology Inc Tissue Heart Valves Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. JenaValve Technology Inc Tissue Heart Valves Device Product Portfolio Table 97. JenaValve Technology Inc Recent Development Table 98. Meril Life Sciences Company Information Table 99. Meril Life Sciences Business Overview Table 100. Meril Life Sciences Tissue Heart Valves Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Meril Life Sciences Tissue Heart Valves Device Product Portfolio Table 102. Meril Life Sciences Recent Development Table 103. On-X Life Technologies, Inc Company Information Table 104. On-X Life Technologies, Inc Business Overview Table 105. On-X Life Technologies, Inc Tissue Heart Valves Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. On-X Life Technologies, Inc Tissue Heart Valves Device Product Portfolio Table 107. On-X Life Technologies, Inc Recent Development Table 108. Sorin Group Company Information Table 109. Sorin Group Business Overview Table 110. Sorin Group Tissue Heart Valves Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Sorin Group Tissue Heart Valves Device Product Portfolio Table 112. Sorin Group Recent Development Table 113. TTK Healthcare Limited Company Information Table 114. TTK Healthcare Limited Business Overview Table 115. TTK Healthcare Limited Tissue Heart Valves Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. TTK Healthcare Limited Tissue Heart Valves Device Product Portfolio Table 117. TTK Healthcare Limited Recent Development Table 118. Beijing Balance Medical Technology Co., Ltd Company Information Table 119. Beijing Balance Medical Technology Co., Ltd Business Overview Table 120. Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Product Portfolio Table 122. Beijing Balance Medical Technology Co., Ltd Recent Development Table 123. Medtronic Company Information Table 124. Medtronic Business Overview Table 125. Medtronic Tissue Heart Valves Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Medtronic Tissue Heart Valves Device Product Portfolio Table 127. Medtronic Recent Development Table 128. Abbott Company Information Table 129. Abbott Business Overview Table 130. Abbott Tissue Heart Valves Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Abbott Tissue Heart Valves Device Product Portfolio Table 132. Abbott Recent Development Table 133. North America Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. North America Tissue Heart Valves Device Sales by Country (2021-2026) & (k units) Table 135. North America Tissue Heart Valves Device Sales Market Share by Country (2021-2026) Table 136. North America Tissue Heart Valves Device Sales Forecast by Country (2027-2032) & (k units) Table 137. North America Tissue Heart Valves Device Sales Market Share Forecast by Country (2027-2032) Table 138. North America Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Tissue Heart Valves Device Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Tissue Heart Valves Device Market Share by Country (2021-2026) Table 141. North America Tissue Heart Valves Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Tissue Heart Valves Device Market Share Forecast by Country (2027-2032) Table 143. Europe Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Europe Tissue Heart Valves Device Sales by Country (2021-2026) & (k units) Table 145. Europe Tissue Heart Valves Device Sales Market Share by Country (2021-2026) Table 146. Europe Tissue Heart Valves Device Sales Forecast by Country (2027-2032) & (k units) Table 147. Europe Tissue Heart Valves Device Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Tissue Heart Valves Device Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Tissue Heart Valves Device Market Share by Country (2021-2026) Table 151. Europe Tissue Heart Valves Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Tissue Heart Valves Device Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Tissue Heart Valves Device Sales by Country (2021-2026) & (k units) Table 155. Asia-Pacific Tissue Heart Valves Device Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Tissue Heart Valves Device Sales Forecast by Country (2027-2032) & (k units) Table 157. Asia-Pacific Tissue Heart Valves Device Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Tissue Heart Valves Device Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Tissue Heart Valves Device Market Share by Country (2021-2026) Table 161. Asia-Pacific Tissue Heart Valves Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Tissue Heart Valves Device Market Share Forecast by Country (2027-2032) Table 163. Latin America Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 164. Latin America Tissue Heart Valves Device Sales by Country (2021-2026) & (k units) Table 165. Latin America Tissue Heart Valves Device Sales Market Share by Country (2021-2026) Table 166. Latin America Tissue Heart Valves Device Sales Forecast by Country (2027-2032) & (k units) Table 167. Latin America Tissue Heart Valves Device Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Tissue Heart Valves Device Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Tissue Heart Valves Device Market Share by Country (2021-2026) Table 171. Latin America Tissue Heart Valves Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Tissue Heart Valves Device Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Tissue Heart Valves Device Sales by Country (2021-2026) & (k units) Table 175. Middle East and Africa Tissue Heart Valves Device Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Tissue Heart Valves Device Sales Forecast by Country (2027-2032) & (k units) Table 177. Middle East and Africa Tissue Heart Valves Device Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Tissue Heart Valves Device Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Tissue Heart Valves Device Market Share by Country (2021-2026) Table 181. Middle East and Africa Tissue Heart Valves Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Tissue Heart Valves Device Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Tissue Heart Valves Device Distributors List Table 186. Tissue Heart Valves Device Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Tissue Heart Valves Device Image Figure 2. Global Tissue Heart Valves Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tissue Heart Valves Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Tissue Heart Valves Device Sales (2021-2032) & (k units) Figure 5. Aortic Valve Image Figure 6. Global Aortic Valve Sales YoY Growth (2021-2032) & (k units) Figure 7. Tricuspid Valve Image Figure 8. Global Tricuspid Valve Sales YoY Growth (2021-2032) & (k units) Figure 9. Pulmonary Valve Image Figure 10. Global Pulmonary Valve Sales YoY Growth (2021-2032) & (k units) Figure 11. Mitral Valve Image Figure 12. Global Mitral Valve Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Tissue Heart Valves Device Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Tissue Heart Valves Device Market Share by Type 2025 VS 2032 Figure 15. North America Tissue Heart Valves Device Sales Market Share in Volume by Type in 2025 Figure 16. North America Tissue Heart Valves Device Sales Market Share in Value by Type in 2025 Figure 17. Europe Tissue Heart Valves Device Sales Market Share in Volume by Type in 2025 Figure 18. Europe Tissue Heart Valves Device Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Tissue Heart Valves Device Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Tissue Heart Valves Device Sales Market Share in Value by Type in 2025 Figure 21. Latin America Tissue Heart Valves Device Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Tissue Heart Valves Device Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Tissue Heart Valves Device Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Tissue Heart Valves Device Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Tissue Heart Valves Device Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Ambulatory Surgical Centers Image Figure 28. Global Ambulatory Surgical Centers Sales YoY Growth (2021-2032) & (k units) Figure 29. Hospitals Image Figure 30. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 31. Clinics Image Figure 32. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Tissue Heart Valves Device Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Tissue Heart Valves Device Market Share by Application 2025 VS 2032 Figure 35. North America Tissue Heart Valves Device Sales Market Share in Volume by Application in 2025 Figure 36. North America Tissue Heart Valves Device Sales Market Share in Value by Application in 2025 Figure 37. Europe Tissue Heart Valves Device Sales Market Share in Volume by Application in 2025 Figure 38. Europe Tissue Heart Valves Device Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Tissue Heart Valves Device Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Tissue Heart Valves Device Sales Market Share in Value by Application in 2025 Figure 41. Latin America Tissue Heart Valves Device Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Tissue Heart Valves Device Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Tissue Heart Valves Device Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Tissue Heart Valves Device Sales Market Share in Value by Application in 2025 Figure 45. North America Tissue Heart Valves Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Tissue Heart Valves Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Tissue Heart Valves Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Tissue Heart Valves Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Tissue Heart Valves Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Tissue Heart Valves Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Tissue Heart Valves Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Tissue Heart Valves Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Tissue Heart Valves Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Tissue Heart Valves Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Tissue Heart Valves Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Tissue Heart Valves Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Tissue Heart Valves Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Tissue Heart Valves Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Tissue Heart Valves Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Tissue Heart Valves Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Tissue Heart Valves Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Tissue Heart Valves Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Tissue Heart Valves Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Tissue Heart Valves Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Tissue Heart Valves Device Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Tissue Heart Valves Device Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Aortic Valve
  • Tricuspid Valve
  • Pulmonary Valve
  • Mitral Valve
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Clinics
Companies covered
  • Boston Scientific Corporation
  • Comed BV
  • CryoLife
  • Edward Lifesciences Corporation
  • JenaValve Technology Inc
  • Meril Life Sciences
  • On-X Life Technologies, Inc
  • Sorin Group
  • TTK Healthcare Limited
  • Beijing Balance Medical Technology Co., Ltd
  • Medtronic
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tissue Heart Valves Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tissue Heart Valves Device Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tissue Heart Valves Device Market by Type
  6. 1.3.1 Aortic Valve
  7. 1.3.2 Tricuspid Valve
  8. 1.3.3 Pulmonary Valve
  9. 1.3.4 Mitral Valve
  10. 1.4 Global Tissue Heart Valves Device Market Size by Type
  11. 1.4.1 Global Tissue Heart Valves Device Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Tissue Heart Valves Device Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Tissue Heart Valves Device Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Tissue Heart Valves Device Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Tissue Heart Valves Device Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Tissue Heart Valves Device Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Tissue Heart Valves Device Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Tissue Heart Valves Device Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tissue Heart Valves Device Industry Trends
  2. 2.2 Tissue Heart Valves Device Industry Drivers
  3. 2.3 Tissue Heart Valves Device Industry Opportunities and Challenges
  4. 2.4 Tissue Heart Valves Device Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tissue Heart Valves Device Revenue (2021-2026)
  2. 3.2 Global Top Players by Tissue Heart Valves Device Sales (2021-2026)
  3. 3.3 Global Top Players by Tissue Heart Valves Device Price (2021-2026)
  4. 3.4 Global Tissue Heart Valves Device Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tissue Heart Valves Device Major Company Production Sites & Headquarters
  6. 3.6 Global Tissue Heart Valves Device Company, Product Type & Application
  7. 3.7 Global Tissue Heart Valves Device Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tissue Heart Valves Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tissue Heart Valves Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tissue Heart Valves Device Tier 1, Tier 2, and Tier 3
4 Tissue Heart Valves Device Regional Status and Outlook
  1. 4.1 Global Tissue Heart Valves Device Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tissue Heart Valves Device Historic Market Size by Region
  3. 4.2.1 Global Tissue Heart Valves Device Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tissue Heart Valves Device Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tissue Heart Valves Device Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tissue Heart Valves Device Forecasted Market Size by Region
  7. 4.3.1 Global Tissue Heart Valves Device Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tissue Heart Valves Device Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tissue Heart Valves Device Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tissue Heart Valves Device by Application
  1. 5.1 Tissue Heart Valves Device Market by Application
  2. 5.1.1 Ambulatory Surgical Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinics
  5. 5.2 Global Tissue Heart Valves Device Market Size by Application
  6. 5.2.1 Global Tissue Heart Valves Device Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Tissue Heart Valves Device Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Tissue Heart Valves Device Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Tissue Heart Valves Device Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Tissue Heart Valves Device Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Tissue Heart Valves Device Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Tissue Heart Valves Device Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Tissue Heart Valves Device Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boston Scientific Corporation
  2. 6.1.1 Boston Scientific Corporation Company Information
  3. 6.1.2 Boston Scientific Corporation Business Overview
  4. 6.1.3 Boston Scientific Corporation Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boston Scientific Corporation Tissue Heart Valves Device Product Portfolio
  6. 6.1.5 Boston Scientific Corporation Recent Developments
  7. 6.2 Comed BV
  8. 6.2.1 Comed BV Company Information
  9. 6.2.2 Comed BV Business Overview
  10. 6.2.3 Comed BV Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Comed BV Tissue Heart Valves Device Product Portfolio
  12. 6.2.5 Comed BV Recent Developments
  13. 6.3 CryoLife
  14. 6.3.1 CryoLife Company Information
  15. 6.3.2 CryoLife Business Overview
  16. 6.3.3 CryoLife Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CryoLife Tissue Heart Valves Device Product Portfolio
  18. 6.3.5 CryoLife Recent Developments
  19. 6.4 Edward Lifesciences Corporation
  20. 6.4.1 Edward Lifesciences Corporation Company Information
  21. 6.4.2 Edward Lifesciences Corporation Business Overview
  22. 6.4.3 Edward Lifesciences Corporation Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Edward Lifesciences Corporation Tissue Heart Valves Device Product Portfolio
  24. 6.4.5 Edward Lifesciences Corporation Recent Developments
  25. 6.5 JenaValve Technology Inc
  26. 6.5.1 JenaValve Technology Inc Company Information
  27. 6.5.2 JenaValve Technology Inc Business Overview
  28. 6.5.3 JenaValve Technology Inc Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 JenaValve Technology Inc Tissue Heart Valves Device Product Portfolio
  30. 6.5.5 JenaValve Technology Inc Recent Developments
  31. 6.6 Meril Life Sciences
  32. 6.6.1 Meril Life Sciences Company Information
  33. 6.6.2 Meril Life Sciences Business Overview
  34. 6.6.3 Meril Life Sciences Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Meril Life Sciences Tissue Heart Valves Device Product Portfolio
  36. 6.6.5 Meril Life Sciences Recent Developments
  37. 6.7 On-X Life Technologies, Inc
  38. 6.7.1 On-X Life Technologies, Inc Company Information
  39. 6.7.2 On-X Life Technologies, Inc Business Overview
  40. 6.7.3 On-X Life Technologies, Inc Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 On-X Life Technologies, Inc Tissue Heart Valves Device Product Portfolio
  42. 6.7.5 On-X Life Technologies, Inc Recent Developments
  43. 6.8 Sorin Group
  44. 6.8.1 Sorin Group Company Information
  45. 6.8.2 Sorin Group Business Overview
  46. 6.8.3 Sorin Group Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sorin Group Tissue Heart Valves Device Product Portfolio
  48. 6.8.5 Sorin Group Recent Developments
  49. 6.9 TTK Healthcare Limited
  50. 6.9.1 TTK Healthcare Limited Company Information
  51. 6.9.2 TTK Healthcare Limited Business Overview
  52. 6.9.3 TTK Healthcare Limited Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 TTK Healthcare Limited Tissue Heart Valves Device Product Portfolio
  54. 6.9.5 TTK Healthcare Limited Recent Developments
  55. 6.10 Beijing Balance Medical Technology Co., Ltd
  56. 6.10.1 Beijing Balance Medical Technology Co., Ltd Company Information
  57. 6.10.2 Beijing Balance Medical Technology Co., Ltd Business Overview
  58. 6.10.3 Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Product Portfolio
  60. 6.10.5 Beijing Balance Medical Technology Co., Ltd Recent Developments
  61. 6.11 Medtronic
  62. 6.11.1 Medtronic Company Information
  63. 6.11.2 Medtronic Business Overview
  64. 6.11.3 Medtronic Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Medtronic Tissue Heart Valves Device Product Portfolio
  66. 6.11.5 Medtronic Recent Developments
  67. 6.12 Abbott
  68. 6.12.1 Abbott Company Information
  69. 6.12.2 Abbott Business Overview
  70. 6.12.3 Abbott Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Abbott Tissue Heart Valves Device Product Portfolio
  72. 6.12.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Tissue Heart Valves Device Sales by Country
  2. 7.1.1 North America Tissue Heart Valves Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tissue Heart Valves Device Sales by Country (2021-2026)
  4. 7.1.3 North America Tissue Heart Valves Device Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tissue Heart Valves Device Market Size by Country
  6. 7.2.1 North America Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tissue Heart Valves Device Market Size by Country (2021-2026)
  8. 7.2.3 North America Tissue Heart Valves Device Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tissue Heart Valves Device Sales by Country
  2. 8.1.1 Europe Tissue Heart Valves Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tissue Heart Valves Device Sales by Country (2021-2026)
  4. 8.1.3 Europe Tissue Heart Valves Device Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tissue Heart Valves Device Market Size by Country
  6. 8.2.1 Europe Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tissue Heart Valves Device Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tissue Heart Valves Device Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tissue Heart Valves Device Sales by Country
  2. 9.1.1 Asia-Pacific Tissue Heart Valves Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tissue Heart Valves Device Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tissue Heart Valves Device Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tissue Heart Valves Device Market Size by Country
  6. 9.2.1 Asia-Pacific Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tissue Heart Valves Device Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tissue Heart Valves Device Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tissue Heart Valves Device Sales by Country
  2. 10.1.1 South America Tissue Heart Valves Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tissue Heart Valves Device Sales by Country (2021-2026)
  4. 10.1.3 South America Tissue Heart Valves Device Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tissue Heart Valves Device Market Size by Country
  6. 10.2.1 South America Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tissue Heart Valves Device Market Size by Country (2021-2026)
  8. 10.2.3 South America Tissue Heart Valves Device Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tissue Heart Valves Device Sales by Country
  2. 11.1.1 Middle East and Africa Tissue Heart Valves Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tissue Heart Valves Device Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tissue Heart Valves Device Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tissue Heart Valves Device Market Size by Country
  6. 11.2.1 Middle East and Africa Tissue Heart Valves Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tissue Heart Valves Device Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tissue Heart Valves Device Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tissue Heart Valves Device Value Chain Analysis
  2. 12.1.1 Tissue Heart Valves Device Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tissue Heart Valves Device Production Mode & Process
  7. 12.2 Tissue Heart Valves Device Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tissue Heart Valves Device Distributors
  10. 12.2.3 Tissue Heart Valves Device Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst